Delivery Order SPE2DR25D1100-SPE2DR26FDA1Y
Award Date 1/16/26
Potential Completion Date 2/9/26
Potential Value $16K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $16,490.94 delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for supply of Itovebi 9 mg tablets (28-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and running through December 2026, which provides pharmaceutical and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is March 16,...
- The Defense Logistics Agency issued a $32,981.88 delivery order to Amerisourcebergen Drug Corp on March 18, 2026, for ITOVEBI 9 mg tablets (28-count). The order is issued under the DLA Troop Support Medical IDC SPE2DX, a single-award indefinite delivery contract valued at $999,999,999.00 and running through December 2026, which supplies pharmaceutical products and medical commodities to support military healthcare programs globally. Place of performance is Conshohocken, PA. The ultimate...
- The Defense Logistics Agency issued a $8,239.06 delivery order to Amerisourcebergen Drug Corp on May 5, 2026, for ITOVEBI 3 mg tablets (28-count package), with ultimate completion on May 27, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. This is a transactional pharmaceutical delivery order under DLA's standing medical supply vehicle, consistent with Amerisourcebergen's role as a primary pharmaceutical distributor to federal defense healthcare...
- <p>The Defense Logistics Agency issued a $32,981.88 delivery order to Amerisourcebergen Drug Corp on May 14, 2026, for ITOVEBI 9 MG tablets (28-count).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of June 5, 2026. No set-aside was used.</p>
- The Defense Logistics Agency issued a $3,333.55 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for pharmaceutical tablets with an ultimate completion date of March 5, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, a global pharmaceutical support vehicle enabling supply of brand-name and generic drugs, vaccines, and medical supplies to military healthcare programs worldwide. Place...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, with a ceiling value of $27,041.46 for orserdu 345 mg tablets (30s). The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a global pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is March 4, 2026. Pricing is firm fixed price. No set-aside applies.
- The Defense Logistics Agency's Medical Supply Chain issued a $16,209.90 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, with an ultimate completion date of February 10, 2026. The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This IDC supports global pharmaceutical supply across multiple therapeutic domains, including brand-name and generic medications, vaccines,...
- The Defense Logistics Agency's Medical Supply Chain issued a $16,514.88 delivery order to AmerisourceBergen Drug Corp on February 9, 2026, for pharmaceutical products. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999.00 and running through December 2026. This IDC serves as a global pharmaceutical support vehicle enabling delivery of brand-name and generic drugs, vaccines, and specialized medical supplies to support military...
- The Defense Logistics Agency Medical Supply Chain issued a $16,684.20 delivery order to Amerisourcebergen Drug Corp on January 15, 2026, under the DLA Troop Support Medical IDC for pharmaceutical products. The parent vehicle is the DLA Troop Support Medical Indefinite Delivery Contract, valued at $999,999,999.00 through December 2026, which supplies a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems globally. Place of performance is Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain issued a $26,646.24 delivery order to AmerisourceBergen Drug Corp on January 13, 2026, under the DLA Troop Support Medical IDC for pharmaceutical supply. The parent vehicle is the DLA Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999 through December 2026, which supports global pharmaceutical and medical supply delivery to military healthcare programs. Place of performance is Conshohocken, PA. The order is firm...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDA1YDelivery Order
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on January 16, 2026, with a ceiling value of $16,478.14 for supply of Itovebi 3 mg tablets (28 count). The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 that provides pharmaceutical and medical supply support to military healthcare systems globally. Place of performance is Conshohocken, PA. The order carries firm fixed pricing with an ultimate completion date of February 9, 2026. No set-aside was used.
Generated 7/2/26, 2:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 1/15/26 |